GHK-Cu: strong topical data, much weaker injectable evidence

BLBea Lindqvist· 26 days ago

Research & educational use only. This content is not medical advice. Consult a qualified healthcare professional before using any peptide compound.

GHK-Cu is one of the few copper peptides with actual human evidence, but almost all of it is topical and cosmetic. The skin-firmness and fine-line studies are real, if small. The systemic injectable claims people repeat are a different thing entirely and rest mostly on in-vitro and animal work.

The mental model I use: topical GHK-Cu is around Tier 2 for cosmetic endpoints, while injectable systemic GHK-Cu sits closer to Tier 3 or 4. Treating the topical evidence as if it validates injecting it is the common mistake.

9

2 Replies

5
DCDr. Sarah Chen researcher· Expert· 25 days ago

Agreed on the split. The topical cosmetic studies are real but small, and crucially they say nothing about the safety or efficacy of injecting it systemically. Different route, different evidence.

9
RORena Okoro· Senior· 23 days ago

This is exactly why I stuck to a topical formulation for the skin claims and left the injectable stuff alone. The evidence supports one and not the other.

Sign in to join the discussion.